PharmSci 2019

September 11-13, 2019 | UK

Reflecting the needs for sustainability and diversity in addressing the health of globally connected populations

Spotlight

Access to medicines for cancer patients is crucial for providing high quality care. However, cancer medicines shortages are a problem affecting countries across Europe. These shortages occur when the supply of medicines, identified as essential by the health system, is insufficient to meet public health and patient needs.1 Why do these shortages exist, and how can we prevent them? The Economist Intelligence Unit were commissioned by the European Society for Medical Oncology (ESMO) to investigate medicines shortages in Europe, what can be done to prevent medicines shortages, explore their impact on the provision of care and how to mitigate the impact on patients, clinicians and pharmacists.


OTHER PAST CONFERENCES

International Conference on Pharmaceutical Chemistry

April 24, 2022 | Seychelles

IIERD is aimed at providing a platform to discuss and enhance the developments in science, technology, management and allied areas to strengthen the core of research with new ideas to nurture.

US PHARMA AND BIOTECH SUMMIT

May 11, 2022 | USA

The US Pharma and Biotech Summit returns to New York on May 11, 2022. Industry leaders and FT journalists will discuss regional and global trends in areas such as drug discovery, clinical development and market access.

Natural Products and Medicinal Plants Research

May 23-24, 2022 | Austria

Conferenceseries LLC Ltd is an amalgamation of Open Access Publications and worldwide international science conferences and events.

HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS

May 9-10, 2022 | UK

The Global High Potency API/HPAPI Market is projected to reach 37 billion USD by 2027, growing at an ever-increasing CAGR of 8.43%. The expanding production of high potency APIs,

Spotlight

Access to medicines for cancer patients is crucial for providing high quality care. However, cancer medicines shortages are a problem affecting countries across Europe. These shortages occur when the supply of medicines, identified as essential by the health system, is insufficient to meet public health and patient needs.1 Why do these shortages exist, and how can we prevent them? The Economist Intelligence Unit were commissioned by the European Society for Medical Oncology (ESMO) to investigate medicines shortages in Europe, what can be done to prevent medicines shortages, explore their impact on the provision of care and how to mitigate the impact on patients, clinicians and pharmacists.

resources